Advertisements

Sertralin HEXAL

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Sertralin HEXAL

Sertralin HEXAL is a prescription-only medicine that contains the active ingredient sertraline (INN). It is classified as an antidepressant belonging to the Selective Serotonin Reuptake Inhibitor (SSRI) class.


Quick Facts

Property Description
Active ingredient Sertraline hydrochloride
Form Film-coated tablet (for oral administration)
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
Common use Treatment of mood and anxiety-related disorders
Origin Synthetic compound

Definition and Composition

Sertralin HEXAL is a generic formulation produced by HEXAL AG, a German-based manufacturer, available as a film-coated tablet intended for oral administration. The synthetic active ingredient is sertraline hydrochloride, provided as a single-ingredient medicine. This product's identity is clinically recognized for its established role in managing mood and anxiety disorders, including panic and social anxiety, particularly in the adult patient group.

Sertraline is used to treat major depressive disorder and various anxiety-related conditions. The conclusion for the patient is that this medicine is a treatment option designed to help manage emotional and mood imbalances.

Pharmacological Class and Purpose

Sertraline's pharmacological identity is defined by its role as an SSRI. This classification signifies that the drug selectively targets the neurotransmitter serotonin in the central nervous system. Its primary function is to inhibit the reuptake of serotonin by nerve cells.

By blocking this reabsorption process, the concentration of serotonin available in the synaptic spaces is increased, which is the action that contributes to the stabilization of neural activity related to mood regulation. SSRIs are a type of antidepressant often prescribed, indicating that they are widely used as a therapy for such conditions. This information assures the patient that the medication belongs to a standard, established class of modern psychotropic drugs with a well-understood mechanism for relieving emotional distress and stabilizing mood.

Regulatory References

  1. Sertraline: MedlinePlus Drug Information
  2. Sertraline - StatPearls - NCBI Bookshelf
Advertisements

What side effects are possible with Sertralin HEXAL?

Possible Side Effects and Safety Information

Official regulatory documents classify the safety profile of Sertralin HEXAL, noting a range of potential side effects and required precautions.

Common Adverse Reactions

The most frequently reported adverse reactions (ge 1/10 or very common) include nausea. Reactions considered common (ge 1/100 to < 1/10) often involve the gastrointestinal and nervous systems, such as diarrhea or loose stools, dry mouth, insomnia, fatigue, dizziness, somnolence, tremor, decreased appetite, agitation, and decreased libido. Sexual dysfunction, including ejaculation failure and decreased libido, is a recognized and frequent adverse effect.

Serious and Clinically Significant Safety Concerns

Sertraline carries a mandatory precaution regarding the increased risk of suicidal thoughts and behaviors in pediatric and young adult patients, particularly during initial treatment or dose adjustment. Other documented serious risks include Serotonin Syndrome or Neuroleptic Malignant Syndrome (NMS)-like reactions, which are possible when co-administered with other serotonergic agents or MAOIs. Abnormal bleeding, activation of mania or hypomania, seizures, hyponatremia (low sodium), angle-closure glaucoma, and dose-dependent QTc prolongation are also documented as significant safety risks. The drug is contraindicated with MAOIs and pimozide.

Population-Specific Safety Considerations

  • Pediatric Use: Safety and effectiveness have generally not been established for diagnoses other than Obsessive-Compulsive Disorder (OCD). Use is associated with the aforementioned increased risk of suicidal ideation and behaviors.
  • Hepatic Impairment: Lower or less frequent dosing is recommended due to reduced drug clearance.
  • Discontinuation: Abrupt cessation should be avoided as it may lead to withdrawal or discontinuation syndrome symptoms, requiring a gradual dose reduction under monitoring.
Advertisements

Overdose and Emergency Response

The official prescribing information details that an overdose of Sertraline may present with a variety of documented clinical manifestations. Common signs involving the central nervous system include somnolence, dizziness, tremor, agitation, and confusion, alongside gastrointestinal disturbances like nausea and vomiting. Other documented effects include tachycardia (rapid heartbeat), sweating, and loss of coordination.

More severe, potentially life-threatening outcomes are documented and require urgent attention. These include seizures, coma, and severe conditions such as Serotonin Syndrome and cardiac abnormalities, specifically QTc prolongation and reports of Torsade de Pointes. Official labeling notes that the risk of death is increased when Sertraline is ingested in combination with other drugs and/or alcohol.

Immediate medical attention is required in any suspected overdose situation. Regulatory authorities mandate that individuals should immediately call emergency services or the poison control helpline if severe symptoms are present, such as loss of consciousness, having a seizure, or difficulty breathing.

Treatment is limited to aggressive symptomatic and supportive measures, as no specific antidote to sertraline is known. Official documents recommend ECG and vital sign monitoring during management. Procedures such as forced diuresis and dialysis are documented as unlikely to be beneficial.

Advertisements

Therapeutic Uses of Sertralin HEXAL

What Sertralin HEXAL Treats: Main Uses and Benefits

Sertralin HEXAL is commonly used to help with a range of conditions and symptoms that interfere with daily functioning across multiple therapeutic domains. The medication is utilized to help manage symptoms of Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder, Post-Traumatic Stress Disorder (PTSD), and Social Anxiety Disorder. The therapeutic support contributes to easing emotional distress and helps manage symptom clusters that may become disruptive. It is relevant in contexts marked by increased discomfort or tension, particularly in long-term management scenarios where supporting general well-being is key.


Stabilizing Persistent Low Mood and Preventing Recurrence

This medicine is applied across domains where additional symptomatic support is needed for conditions marked by increased physiological stress and persistent low mood, hopelessness, and loss of interest. It supports the patient during difficult episodes, helping to maintain a sense of stability when symptoms are more noticeable, and may assist with the prevention of recurrence of major depressive episodes.


Easing Severe Anxiety and Compulsive Patterns

Sertralin HEXAL is relevant in contexts involving acute or disruptive symptom patterns, particularly associated with intense, fear-based symptoms. It is used for managing symptom clusters, including panic attacks and pervasive worry. Furthermore, it may assist with the symptomatic management of highly distressing unwanted, intrusive thoughts and repetitive behaviors characteristic of OCD.


Quick Fact: Relief for Episodic Distress

The medication is utilized in conditions characterized by periods of heightened symptoms such as cyclical premenstrual mood swings (PMDD). It is applied in addressing anxiety and hyper-arousal symptoms following a traumatic event, helping patients cope more steadily with symptom fluctuations.

Regulatory References

  1. National Institutes of Health (NIH) MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Sertralin HEXAL — Official Regulatory Information


Eligibility Scope

Category Official Regulatory Status Contextual Details (as stated in label)
Populations for whom use is allowed Adults (18+ years) for all approved uses. Pediatric patients (6-17 years) are eligible only for the treatment of Obsessive-Compulsive Disorder (OCD).
Populations for whom use is contraindicated Absolute non-eligibility. Patients taking, or within 14 days of stopping, a Monoamine Oxidase Inhibitor (MAOI), or patients taking pimozide.

Age-Related Eligibility and Restrictions

  • Safety and effectiveness have not been established in children under 6 years of age.
  • Use in adolescents for indications other than OCD is not recommended.
  • Use in older adults requires special consideration due to potential elevated risks documented in labeling.

Condition-Specific Eligibility Rules

  • Use is not recommended for patients with severe hepatic impairment (liver disease) due to significantly reduced clearance.
  • Caution is required for patients with mild to moderate hepatic impairment, seizure disorders, a history of bipolar disorder, or documented risk factors for QTc prolongation.

Pregnancy and Lactation Eligibility Status

  • Use during the third trimester of pregnancy may increase the risk for persistent pulmonary hypertension and other symptoms in the neonate.
  • Sertraline may pass into breast milk.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines interactions with other substances that are officially documented in government regulatory labeling for sertraline. All statements reflect the high-level descriptions of interaction patterns and restrictions.

Contraindicated and Restricted Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated due to the risk of Serotonin Syndrome; a minimum of 14 days must elapse between stopping an MAOI and starting this medicine, or vice-versa. The use of Pimozide is also contraindicated because sertraline significantly increases its plasma concentration, raising the risk of serious cardiac events. The oral solution formulation is contraindicated with Disulfiram due to its alcohol content.

Pharmacokinetic and Pharmacodynamic Interactions

Sertraline is documented as a mild inhibitor of the CYP2D6 enzyme. Co-administration with drugs primarily metabolized by CYP2D6 (such as certain tricyclic antidepressants) may result in their reduced clearance and increased plasma levels, as described in regulatory documents.

Interactions Affecting Hemostasis

Co-administration with substances that interfere with blood coagulation, including Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and anticoagulants such as Warfarin, carries an officially documented increased risk of bleeding.

Food, Alcohol, and Exposure Notes

Administration of the tablet with food results in a documented 25% increase in the drug's maximum plasma concentration (C max). The consumption of alcohol is officially recommended to be avoided during treatment. Use with the herbal product St. John's wort is also advised against due to the risk of increased serotonergic effects.

Advertisements

Mechanism of Action

Sertraline HEXAL operates by modulating key signaling pathways in the central nervous system, resulting in the modification of signaling dynamics. Its primary mechanism is classified as a selective serotonin reuptake inhibitor (SSRI).


Selective Serotonin Reuptake Inhibition

Sertraline's core pharmacodynamic action involves blocking the reabsorption, or reuptake, of the neurotransmitter serotonin (5-HT) by the presynaptic nerve terminal. This inhibition is mediated by binding to the serotonin transporter (SERT) protein . By inhibiting SERT, the drug increases the concentration and duration of serotonin's presence in the synaptic cleft. This augmented signaling engages postsynaptic receptor pathways that consequently modify the excitability of related neural circuits.


Neurotransmitter System Modulation

Beyond its effect on the serotonin system, the drug exhibits high functional selectivity for SERT over other monoamine transporters. This selectivity contributes to altered signaling within targeted pathways. Additionally, chronic administration is hypothesized to induce subtle neuroplastic changes in specific central nervous system pathways, influencing long-term cellular adaptation.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Sertraline is for oral administration and must be taken once daily, either in the morning or the evening. Tablets may be taken with or without food.

Official Dosing and Titration Rules

Condition Initial Dose (Adults) Dose Titration (Maximum)
Depression, OCD 50 mg once daily 25-50 mg increments, once weekly (Max: 200 mg/day)
Panic Disorder, PTSD, Social Anxiety Disorder 25 mg once daily, increased to 50 mg after one week 50 mg increments, once weekly (Max: 200 mg/day)
PMDD (Continuous) 50 mg once daily 50 mg increments per cycle (Max: 150 mg/day)

For Obsessive-Compulsive Disorder (OCD) in children aged 6–12 years, the recommended starting dose is 25 mg daily, increasing to 50 mg daily after one week. Adolescents (13–17 years) start at 50 mg daily. Dose increases for all groups, if needed, should not occur at intervals of less than one week and should not exceed the maximum daily dose of 200 mg, except for PMDD continuous dosing (150 mg). Patients with mild to moderate hepatic impairment should use a lower or less frequent dose.

Preparation and Missed Dose Instructions

Sertraline oral concentrate must always be diluted immediately before use. It should be mixed with 1/2 cup (4 ounces) of water, ginger ale, lemon-lime soda, lemonade, or orange juice; no other liquids are permitted. If a dose is forgotten, skip the missed dose and take the next dose at the regular time. Do not take a double dose to compensate for the missed one. When discontinuing treatment, the dose should be gradually reduced.

Advertisements

Recent Clinical Evidence

Sertralin HEXAL: Recent Clinical Evidence

Recent clinical evidence regarding Sertralin HEXAL (sertraline) focuses on confirming its established role across various psychiatric conditions and evaluating long-term safety profiles.


Overview of Clinical Trial Findings

Sertraline is a selective serotonin reuptake inhibitor (SSRI). Research has primarily evaluated its efficacy in major depressive disorder (MDD), panic disorder, and obsessive-compulsive disorder (OCD).

Efficacy and Endpoint Measures

Meta-analyses of randomized controlled trials (RCTs) examining MDD report that treatment with sertraline is associated with a reduction in symptom severity as measured by standardized scales (e.g., HAM-D or MADRS). These studies emphasize that an effect on symptoms may take several weeks of treatment to become measurable.

Studies in anxiety disorders (such as panic disorder) evaluated endpoints related to the frequency and intensity of panic attacks. Findings indicate that treatment is generally associated with a decrease in the frequency of these episodes compared to placebo.

Long-Term Safety and Tolerability

Trials evaluating long-term use (up to one year) have focused on adverse events and rates of treatment discontinuation. Sertraline is generally considered well-tolerated, with common side effects including gastrointestinal upset and sexual dysfunction, which frequently lead to initial discontinuation.

Research continues to monitor potential safety concerns, including the risk of withdrawal symptoms upon discontinuation and potential effects on weight and metabolism during extended use.


Conclusion of Evidence

The body of evidence supports the continued use of sertraline as a standard first-line treatment for its indicated conditions. However, research highlights variability in individual patient response and the need for personalized dosing strategies. Sustained long-term safety data is continuously gathered to ensure a complete risk-benefit assessment.

Key Studies & References

  1. Guideline for the pharmacological treatment of mental disorders in primary care. Sertraline: Treatment of Depressive Disorders
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Sertralin HEXAL (FAQ)


Q: Is Sertralin HEXAL the exact same medicine as Zoloft?

Sertralin HEXAL contains the active ingredient sertraline, which is the generic name for the brand-name medicine Zoloft. Regulatory documents confirm generic sertraline is bioequivalent to Zoloft. The difference primarily relates to the manufacturer and the specific formulation name.


Q: How does Sertralin HEXAL generally differ from other SSRI medicines?

Official regulatory documents indicate that sertraline is approved for a broader range of indications and age groups (e.g., OCD in pediatric patients) compared to some other medicines in the same SSRI class.


Q: Does Sertralin HEXAL cause weight gain for most people?

The effect on weight may vary among individuals. Clinical trial data lists both decreased appetite and weight loss as a common adverse reaction. Weight increase is also reported as a less common reaction, according to the official product information.


Q: Are headaches a common side effect when first starting Sertralin HEXAL?

Headache is explicitly listed in regulatory labeling as a common adverse event experienced by patients in clinical trials, especially during the initial phase of treatment.


Q: Is Sertralin HEXAL an addictive medicine?

Sertraline has not demonstrated potential for abuse in human studies and is not classified as a controlled substance. However, official guidance states that abruptly stopping treatment may cause discontinuation symptoms, and the process for cessation requires a gradual dose reduction as described in product labeling.


Q: Are there specific foods that should be avoided when taking Sertralin HEXAL?

Official regulatory documents describe that consumption of grapefruit or grapefruit juice is not recommended with sertraline. This non-recommendation is due to reports that grapefruit may increase the blood levels of the medication, which may raise the risk of side effects.


Q: What is the expected timeline for feeling the full benefits of Sertralin HEXAL?

The time it takes to feel the full effects can vary based on the condition being treated. According to official product information, it may take approximately 4 to 6 weeks of regular dosing to experience the full effect for Major Depressive Disorder, and up to 12 weeks for certain anxiety-related conditions like OCD or PTSD.


Q: What do studies say about the long-term effectiveness of Sertraline?

Clinical studies have examined the continued use of sertraline in certain conditions. Official documents demonstrate that the effectiveness of the drug is maintained for periods of up to 52 weeks in conditions such as Obsessive-Compulsive Disorder (OCD) when treatment is continued.


Q: Does research suggest Sertralin HEXAL is effective for social anxiety?

Regulatory authorities have approved sertraline for the treatment of Social Anxiety Disorder (Social Phobia) in adults. This regulatory approval reflects that clinical studies have provided sufficient evidence of its efficacy for this indication.


Q: How is 'serotonin syndrome' described in relation to Sertralin HEXAL?

Serotonin syndrome is a potentially serious reaction documented in regulatory warnings. Symptoms may include a sudden change in mental state (such as agitation or hallucinations), rapid heart rate, sudden onset of sweating and fever, muscle rigidity, and loss of coordination.


Q: Does Sertralin HEXAL have to be taken at the exact same time every day?

The official administration guidelines state that the medicine is prescribed to be taken once daily. To maintain stable blood levels, regulatory information indicates the importance of taking the dose consistently, either in the morning or the evening.


Q: How long do initial side effects from Sertralin HEXAL typically last?

The duration of side effects is variable, but official reports indicate that initial adverse reactions like nausea and dizziness often subside within the first few weeks of starting the drug.


Q: Is sweating or feeling flushed a known side effect of Sertralin HEXAL?

Increased sweating is explicitly listed in regulatory labeling as a common adverse reaction experienced by patients during clinical trials. Feeling flushed is generally not listed as a common reaction.


Q: Can over-the-counter cold medicines be taken with Sertralin HEXAL?

Regulatory documents include warnings about the combination of sertraline with many over-the-counter cold medicines that contain sympathomimetic agents. Official labeling states that this combination may increase the risk of certain side effects.


Q: Can Sertralin HEXAL lead to vivid dreams or nightmares?

Abnormal dreams and nightmares have been reported as adverse reactions in post-marketing and clinical trial data for sertraline. This is a recognized change in sleep patterns for some individuals.


Q: Does Sertralin HEXAL affect coordination or the ability to drive in the first weeks?

Regulatory labeling includes a caution that the medicine may impair the mental and/or physical abilities required for the performance of hazardous tasks. This caution specifically mentions operating machinery or driving a motor vehicle.


Q: Can Sertralin HEXAL cause jaw clenching or teeth grinding?

Adverse events related to muscle movement have been reported during post-marketing use of sertraline. These reports include issues such as bruxism (teeth grinding), dystonia (involuntary muscle contractions), and tremor.


Q: Why do people sometimes feel worse before they feel better on Sertralin HEXAL?

Official warnings note that sertraline is associated with the risk of worsening depression or the emergence of suicidal thoughts and behaviors. This is particularly observed in younger patients during the initial few months of treatment or following dose adjustments.

Advertisements

How should Sertralin HEXAL be stored and disposed of?

Storage and Disposal of Sertralin HEXAL

Sertraline tablets must be stored according to official regulatory requirements to ensure product integrity and public safety.

Storage Conditions

Requirement Details
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep the medicine away from excess heat, moisture, and direct light. The tablets must also be kept from freezing.
Container Keep the tablets in their original container with the lid tightly closed.

Child Safety and Disposal

The product must be stored out of the sight and reach of children, typically secured with a locked safety cap.

Expired or unused Sertralin HEXAL must be disposed of properly. Official guidance strongly recommends utilizing a drug take-back program. If no program is available, the tablets must be mixed with an undesirable substance, placed in a sealed bag, and discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sertralin HEXAL found in:

A-Z Index: